Trial Profile
Insulin glargine with step-wise addition of insulin glulisine or with one injection of insulin glulisine vs a twice-daily premixed insulin regimen (insulin aspart mix 70/30) in adult subjects with type-2 diabetes failing dual or triple therapy with oral agents.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin aspart/insulin protamine aspart; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 12 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD-2011).
- 28 Jun 2011 Patient reported outcomes presented at the 71st Annual Scientific Sessions of the American Diabetes Association.